Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients

Table 1 Baseline characteristics of 154 patients who underwent potential curative cholecystectomy n (%)

Characteristic	Patients (n = 154)
Age (yr)	64 (29-85)
≤ 60	56 (36.4)
> 60	98 (63.6)
Sex
Male	63 (40.9)
Female	91 (59.1)
Cholecystolithiasis
Absent	79 (51.3)
Present	75 (48.7)
Diabetes
Absent	116 (75.3)
Present	38 (24.7)
Jaundice
Absent	129 (83.8)
Present	25 (8.9)
Blood groups
A	43 (27.9)
B	56 (36.4)
AB	9 (5.8)
O	46 (29.9)
Pathological types
Adenosquamous carcinoma	3 (1.9)
Adenocarcinoma	150 (97.4)
Papillocarcinoma	1 (0.6)
Degree of differentiation
Poor	60 (39.0)
Moderate-well	94 (61.0)
Resection margin status
Negative	96 (62.3)
Positive	58 (37.7)
Maximum tumor diameter (cm)	3 (0.2-13)
≤ 2.45	68 (44.2)
> 2.45	86 (55.8)
T stage
Tis-T1a	10 (6.5)
T1b-T2b	29 (18.8)
T3	103 (66.9)
T4	12 (7.8)
N stage
0	98 (63.6)
1	47 (30.5)
2	9 (5.8)
Distant metastasis
Absent	142 (92.2)
Present	12 (7.8)
TNM stage
0-I stage	16 (10.4)
IIA-IIB stage	16 (10.4)
IIIA-IIIB stage	92 (59.7)
IVA-IVB stage	30 (19.5)
CA199 (U/mL)	69.3 (0.6-10524)
≤ 25.45	57 (37.0)
> 25.45	97 (63.0)
Fibrinogen concentration (g/L)	3.54 (1.71-7.47)
≤ 3.47	75 (48.7)
> 3.47	79 (51.3)